Multiple sclerosis is a complex lifelong condition, with the severity of symptoms varying greatly between patients. In this article, requested by visitors to the www.behindthemedicalheadlines.com site, Professor Carolyn Young provides an overview of the different sub-types of MS and the diverse treatments which are currently available for this disease.
Get full access to this article
View all access options for this article.
References
1.
YoungCA.Improving the care of patients with progressive multiple sclerosis: an evidence-based approach. Proc R Coll Physicians Edinb 2002; 32:19–23.
2.
WolinskyJS.The use of glatiramer acetate in the treatment of multiple sclerosis. Adv Neurol 2006; 98:273–92.
GoodinDS.Treatment of multiple sclerosis with human beta interferon. Int MS J 2005; 12(3):96–108.
6.
PolmanCHPWO’ConnorHavrdova E et al;AFFIRM Investigators. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006; 354(9):899–910.
7.
Martinelli Boneschi F, Rovaris M Mitoxantrone for multiple sclerosis. Cochrane Database Syst Rev 2005; (4):CD002127.
Mills RJ,Yap L,Young CA. Treatment for Ataxia in Multiple Sclerosis (review). Cochrane Database Syst Rev 2007; (1):CD005029.
10.
BrazeltonTRFMRossiGIKeshetBlauHM.From marrow to brain: expression of neuronal phenotypes in adult mice from adult bone marrow-derived cells. Science 2000; 290:1775–9.
